Randomized placebo-controlled trial of canakinumab in Schnitzler syndrome
Krause K, et al.
Pediatr Rheumatol · 2015
Key Findings
- ●Randomized placebo-controlled study confirming canakinumab effectiveness
- ●Only RCT conducted in Schnitzler syndrome
Referenced in (1 disease)
Validation history
Full log →No validation events recorded yet. Source will be checked on the next kipine-source-validator run.
ID: manual-k-2015-randomized-placebocontrolled-trial